eribulin mesylate
(Eribulin Mesylate)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Usage: Eribulin mesylate injection is indicated for treating metastatic breast cancer in patients who have received at least two prior chemotherapeutic regimens, including an anthracycline and a taxane. It is also used for unresectable or metastatic liposarcoma in those who have received a prior anthracycline-containing regimen.